AU3129299A - Non-elastomeric polyurethane compositions - Google Patents

Non-elastomeric polyurethane compositions Download PDF

Info

Publication number
AU3129299A
AU3129299A AU31292/99A AU3129299A AU3129299A AU 3129299 A AU3129299 A AU 3129299A AU 31292/99 A AU31292/99 A AU 31292/99A AU 3129299 A AU3129299 A AU 3129299A AU 3129299 A AU3129299 A AU 3129299A
Authority
AU
Australia
Prior art keywords
polyurethane composition
diisocyanate
chain extender
polyurethane
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU31292/99A
Other versions
AU740402B2 (en
Inventor
Raju Adhikari
Pathiraja Arachchillage Gunatillake
Simon John Mccarthy
Gordon Francis Meijs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aortech International PLC
Original Assignee
Aortech International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP2688A external-priority patent/AUPP268898A0/en
Application filed by Aortech International PLC filed Critical Aortech International PLC
Priority to AU31292/99A priority Critical patent/AU740402B2/en
Publication of AU3129299A publication Critical patent/AU3129299A/en
Assigned to ELASTOMEDIC PTY LIMITED reassignment ELASTOMEDIC PTY LIMITED Alteration of Name(s) of Applicant(s) under S113 Assignors: CARDIAC CRC NOMINEES PTY LIMITED
Assigned to AORTECH BIOMATERIALS PTY LTD reassignment AORTECH BIOMATERIALS PTY LTD Amend patent request/document other than specification (104) Assignors: ELASTOMEDIC PTY LIMITED
Application granted granted Critical
Publication of AU740402B2 publication Critical patent/AU740402B2/en
Assigned to AORTECH INTERNATIONAL PLC reassignment AORTECH INTERNATIONAL PLC Alteration of Name(s) in Register under S187 Assignors: AORTECH BIOMATERIALS PTY LTD
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Description

WO 99/50327 PCT/AU99/00236 -1 NON-ELASTOMERIC POLYURETHANE COMPOSITIONS The present invention relates to non-elastomeric polyurethane compositions based on silicon-containing chain extenders characterised by high flexural 5 modulus, high glass transition and heat distortion temperatures. These polyurethane compositions are useful for applications requiring high impact resistance, flexural strength, and other structural properties similar to engineering thermoplastics, and in particular for use in above ambient temperature end-use environments. 10 Polyurethanes represents a broad class of materials formed by reacting chemical compounds bearing functional groups such as isocyanate and hydroxyl. A wide range of polymers with a variety of properties ranging from elastomers to rigid materials can be prepared by selecting a suitable combination of reagents in various proportions. Of these materials, polyurethane elastomers formed by 15 reacting a polyol (typical molecular weight 500 to 4000) with a diisocyanate and a chain extender (low molecular weight diol of molecular weight less than 500), form an important class of commercially useful materials. The methods of synthesis and studies on structure property relationships of these materials are abundant in the polyurethane literature'. 20 The polyurethanes formed by reacting only the chain extender and the diisocyanate are generally very rigid with high flexural modulus, and are often difficult to process due to high melting temperatures. For example, a polyurethane prepared from a common diisocyanate 4,4'-methylenediphenyldiisocyanate (MDI) and 1,4-butanediol (BDO) generally melts at temperatures above 210 0 C which is 25 well above the thermal decomposition temperature of the urethane linkage 2 . Further, such materials are generally very brittle and have poor mechanical properties. Alternatively, harder grades of polyurethane elastomers prepared using a relatively lower proportion of the polyol component usually have a low heat distortion temperatures, primarily due to the presence of the polyol component, 30 usually with a glass transition below ambient temperature.
WO 99/50327 PCT/AU99/00236 -2 Development of polyurethane compositions with high flexural modulus combined with high heat distortion temperatures and thermal processability would provide a new range of rigid materials with strength required for applications in high temperature end-use environments. 5 The hard polyurethane compositions disclosed in US Patent No. 4,101,529 are made by reacting polyisocyanates with mixtures of cycloaliphatic diols and low molecular weight diol chain extenders such as ethylene glycol and low molecular weight active hydrogen containing materials such as trimethylolpropane, and optionally a polymeric polycarbonate diol. These compositions are characterised 10 by heat distortion temperature of at least 88oC (measured by ASTM D-648 at 264 psi) and hardness of at least 75 Shore D. Similarly, US Patent No. 4,808,690 discloses polyurethane compositions with high heat distortion temperatures that are highly cross-linked, and are made by reacting a polyisocyanate prepolymer and a polyhydric alcohol having from 2 to 8 hydroxyl groups in combination with a 15 polyester polyol. Such polyurethanes are expected to be difficult to thermally process due to their highly cross-linked nature. United States Patent No. 4,822,827 describes thermoplastic polyurethane compositions with high glass transition temperatures based on reacting a polyisocyanate and a particular combination of chain extenders including 20 cycloalkane diol, optionally in the presence of a minor amount of high molecular weight polyol. It is also disclosed that only certain members of the new polymers are optically clear. The compositions disclosed in US Patent No. 4,101,529, US Patent No. 4,393,186, US Patent No. 4,808,690 and US Patent No. 4,822,827 all contain a 25 polyol for example polyester, polycarbonate or polyether as part of the polyurethane structure. This would make the prior art compositions susceptible to possible degradation under oxidative and hydrolytic environments, particularly high temperature environments which may limit their applications. Development of new polyurethane compositions which are free of segments derived from 30 polyols while overcoming most of the disadvantages of the prior art compositions, WO 99/50327 PCT/AU99/00236 -3 would broaden the applications of these materials to areas such as medical devices and implants. Accordingly, a requirement exists to develop polyurethanes which are easily processable and have a high flexural modulus, high heat distortion 5 temperature, optical clarity, and resistance to degradation. According to one aspect, the present invention provides a non-elastomeric polyurethane composition which includes a chain extender of the general formula (1) Ri ' R2 I I HO-Rs-Si- R 7 -Si -R 6 -OH (1) I I
R
3 R4) 10 wherein
R
1 , R 2 , R 3 , R 4 , R 5 and R6 are the same or different and selected from an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical; R7 is a divalent linking group or an optionally substituted straight chain, 15 branched or cyclic, saturated or unsaturated hydrocarbon radical; and n is 0 or greater, preferably 2 or less. The term "non-elastomeric" in the present context refers to polyurethanes having a % elongation of up to about 200%, generally up to about 100%. The term "chain extender" in the present context means any compound 20 having at least two functional groups per molecule capable of reacting with the isocyanate group and generally in the molecular weight range 60 to about 500, more preferably 60 to about 450.
WO 99/50327 PCT/AU99/00236 -4 Preferably, the chain extender of formula (1) has a molecular weight of about 500 or less. The hydrocarbon radical for substituents R 1 , R 2 , R 3 and R 4 may include 5 alkyl, alkenyl, alkynyl, aryl and heterocyclyl radicals. It will be appreciated that the equivalent radicals may be used for substituents Rs, R 6 and R 7 except that the reference to alkyl, alkenyl and alkynyl should be to alkylene, alkenylene and alkynylene, respectively. In order to avoid repetition, only detailed definitions of alkyl, alkenyl and alkynyl are provided hereinafter. 10 The term "alkyl" denotes straight chain, branched or mono- or poly-cyclic alkyl, preferably C 1
-
12 alkyl or cycloalkyl. Examples of straight chain and branched alkyl include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec butyl, amyl, isoamyl, sec-amyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, pentyl, hexyl, 4-methylpentyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 1,1 15 dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,2-dimethylbutyl, 1,3 dimethylbutyl, 1,2,2-trimethylpropyl, 1,1,2-trimethylpropyl, heptyl, 5 methylhexyl, 1-methylhexyl, 2,2-dimethylpentyl, 3,3-dimethylpentyl, 4,4 dimethylpentyl, 1,2-dimethylpentyl, 1,3-dimethylpentyl, 1,4-dimethylpentyl, 1,2,3-trimethylbutyl, 1,1,2-trimethylbutyl, 1,1,3-trimethylbutyl, octyl, 6 20 methylheptyl, 1-methylheptyl, 1,1,3,3-tetramethylbutyl, nonyl, 1-, 2-, 3-, 4-, 5-, 6- or 7-methyloctyl, 1-, 2-, 3-, 4- or 5-ethylheptyl, 1-, 2- or 3-propylhexyl, decyl, 1-, 2-, 3-, 4-, 5-, 6-, 7- and 8-methylnonyl, 1-, 2-, 3-, 4-, 5- or 6-ethyloctyl, 1-, 2-, 3- or 4-propylheptyl, undecyl 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-methyldecyl, 1-, 2-, 3-, 4-, 5-, 6- or 7-ethylnonyl, 1-, 2-, 3-, 4- or 5-propyloctyl, 1-, 2- or 3 25 butylheptyl, 1-pentylhexyl, dodecyl, 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- or 10 methylundecyl, 1-, 2-, 3-, 4-, 5-, 6-, 7- or 8-ethyldecyl, 1-, 2-, 3-, 4-, 5- or 6 propylnonyl, 1-, 2-, 3- or 4-butyloctyl, 1,2-pentylheptyl and the like. Examples of cyclic alkyl include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl and the like. 30 The term "alkenyl" denotes groups formed from straight chain, branched or mono- or poly-cyclic alkenes including ethylenically mono- or poly- WO 99/50327 PCT/AU99/00236 -5 unsaturated alkyl or cycloalkyl groups as defined above, preferably C 2
-
12 alkenyl. Examples of alkenyl include vinyl, allyl, 1-methylvinyl, butenyl, iso-butenyl, 3 methyl-2-butenyl, 1-pentenyl, cyclopentenyl, 1-methyl-cyclopentenyl, 1 hexenyl, 3-hexenyl, cyclohexenyl, 1-heptenyl, 3-heptenyl, 1-octenyl, 5 cyclooctenyl, 1-nonenyl, 2-nonenyl, 3-nonenyl, 1-decenyl, 3-decenyl, 1,3 butadienyl, 1,4-pentadienyl, 1,3-cyclopentadienyl, 1,3-hexadienyl, 1,4 hexadienyl, 1,3-cyclohexadienyl, 1,4-cyclohexadienyl, 1,3-cycloheptadienyl, 1,3,5-cycloheptatrienyl, 1,3,5,7-cycloocta-tetraenyl and the like. The term "alkynyl" denotes groups formed from straight chain, branched, 10 or mono- or poly-cyclic alkynes. Examples of alkynyl include ethynyl, 1 propynyl, 1- and 2-butynyl, 2-methyl-2-propynyl, 2-pentynyl, 3-pentynyl, 4 pentynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 10-undecynyl, 4-ethyl-1 octyn-3-yl, 7-dodecynyl, 9-dodecynyl, 10-dodecynyl, 3-methyl-1-dodecyn-3-yl, 2-tridecynyl, 11-tridecynyl, 3-tetradecynyl, 7-hexadecynyl, 3-octadecynyl and 15 the like. The term "aryl" denotes single, polynuclear, conjugated and fused residues of aromatic hydrocarbons. Examples of aryl include phenyl, biphenyl, terphenyl, quaterphenyl, phenoxyphenyl, naphthyl, tetrahydronaphthyl, anthracenyl, dihydroanthracenyl, benzanthracenyl, dibenzanthracenyl, 20 phenanthrenyl and the like. The term "heterocyclyl" denotes mono- or poly-cyclic heterocyclyl groups containing at least one heteroatom selected from nitrogen, sulphur and oxygen. Suitable heterocyclyl groups include N-containing heterocyclic groups, such as, unsaturated 3 to 6 membered heteromonocyclic groups containing 1 to 4 25 nitrogen atoms, for example, pyrrolyl, pyrrolinyl, imidazolyl, pyrazolyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazolyl or tetrazolyl; saturated 3 to 6 membered heteromonocyclic groups containing 1 to 4 nitrogen atoms, such as pyrrolidinyl, imidazolidinyl, piperidino or piperazinyl; unsaturated condensed heterocyclic groups containing 1 to 5 nitrogen atoms, such as, indolyl, 30 isoindolyl, indolizinyl, benzimidazolyl, quinolyl, isoquinolyl, indazolyl, benzotriazolyl or tetrazolopyridazinyl; unsaturated 3 to 6-membered WO 99/50327 PCT/AU99/00236 -6 heteromonocyclic group containing an oxygen atom, such as, pyranyl or furyl; unsaturated 3 to 6-membered hetermonocyclic group containing 1 to 2 sulphur atoms, such as, thienyl; unsaturated 3 to 6-membered heteromonocyclic group containing 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, such as, oxazolyl, 5 isoazolyl or oxadiazolyl; saturated 3 to 6-membered heteromonocyclic group containing 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, such as, morpholinyl; unsaturated condensed heterocyclic group containing 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, such as, benzoxazolyl or benzoxadiazolyl; unsaturated 3 to 6-membered heteromonocyclic group containing 1 to 2 sulphur atoms and 1 to 3 10 nitrogen atoms, such as thiazolyl or thiadiazolyl; saturated 3 to 6-membered heteromonocyclic group containing 1 to 2 sulphur atoms and 1 to 3 nitrogen atoms, such as, thiadiazolyl; and unsaturated condensed heterocyclic group containing 1 to 2 sulphur atoms and 1 to 3 nitrogen atoms, such as benzothiazolyl or benzothiadiazolyl. 15 In this specification, "optionally substituted" means that a group may or may not be further substituted with one or more groups selected from oxygen, nitrogen, sulphur, alkyl, alkenyl, alkynyl, aryl, halo, haloalkyl, haloalkenyl, haloalkynyl, haloaryl, hydroxy, alkoxy, alkenyloxy, alkynyloxy, aryloxy, carboxy, benzyloxy, haloalkoxy, haloalkenyloxy, haloalkynyloxy, haloaryloxy, 20 nitro, nitroalkyl, nitroalkenyl, nitroalkynyl, nitroaryl, nitroheterocyclyl, azido, amino, alkylamino, alkenylamino, alkynylamino, arylamino, benzylamino, acyl, alkenylacyl, alkynylacyl, arylacyl, acylamino, acyloxy, aldehydo, alkylsulphonyl, arylsulphonyl, alkylsulphonylamino, arylsulphonylamino, alkylsulphonyloxy, arylsulphonyloxy, heterocyclyl, heterocycloxy, 25 heterocyclylamino, haloheterocyclyl, alkylsulphenyl, arylsulphenyl, carboalkoxy, carboaryloxy, mercapto, alkylthio, arylthio, acylthio and the like. Suitable divalent linking groups for R 7 include O, S and NR wherein R is hydrogen or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical. 30 Preferred chain extenders of formula (1) are 1,3-bis(4-hydroxybutyl) WO 99/50327 PCT/AU99/00236 -7 -tetramethyl disiloxane (compound of formula (1) wherein R 1 , R 2 , R 3 and R 4 are methyl, R5 and R 6 are butyl and R 7 is O), 1,4-bis(3-hydroxypropyl)tetramethyl disilylethylene (compound of formula (1) wherein R 1 , R 2 , R 3 and R 4 are methyl,
R
5 and R6 are propyl and R 7 is ethylene) and 1,4-bis(3 5 hydroxypropyl)tetramethyl disiloxane. In a preferred embodiment, the chain extender of formula (1) defined above is combined with a chain extender known in the art of polyurethane manufacture. According to another aspect the present invention provides a non 10 elastomeric polyurethane composition which includes a chain extender of general formula (1) defined above and a chain extender known in the art of polyurethane manufacture. The chain extender known in the art of polyurethane manufacture is preferably selected from the group comprising 1,4-butanediol, 1,6-hexanediol, 15 1,8-octanediol, 1,9-nonanediol, 1,10-decanediol, 1,12-dodecanediol, 1,4 cyclohexanedimethanol, 1,4-cyclohexanediols and isomers thereof, hydroxyquinone bix(2-hydroxyethyl) ether, 2-ethyl-1,3-hexanediol, 2-butyl-2 ethyl- 1,3-propanediol, 2,2,4-trimethyl-1,3-pentanediol and mixtures thereof. 1,4-cyclohexanedimethanol and 1,4 butanediol are especially preferred. 20 The silicon chain extender can be used alone or in a range of combinations with known chain extenders. Higher molar percentages of the conventional chain extenders, particularly cycloalkane diols, lead to polyurethane compositions with improved mechanical properties and heat distortion temperatures. Accordingly, a preferred chain extender combination 25 includes a silicon chain extender of formula (1) and a cycloalkane diol chain extender. Although the preferred chain extender mixture contains one silicon chain extender of formula (1) conventional chain extender, it is understood that mixtures containing more than two diols may be used in formulations. 30 WO 99/50327 PCT/AU99/00236 -8 The silicon chain extender can be conveniently prepared by methods reported in the literature 3 . Further, the compounds such as 1,3-bis(3 hydroxypropyl)tetramethyl disiloxane (BPTD) and 1,3-bis(4 hydroxybutyl)tetramethyldisiloxane (BHTD) are available commercially. A 5 range of such silicon-based chain extenders can also be prepared by using hydrosilylation reaction of the appropriate hydroxy alkene and 1,1,3,3 tetramethyldisiloxane using catalyst such as the Wilkinson's catalyst. The polyurethane composition of the present invention generally also includes a polyisocyanate. 10 Thus, the present invention also provides a non-elastomeric polyurethane composition which includes a chain extender of formula (1) defined above and a polyisocyanate. The polyisocanates that can be used in the present invention are preferably diisocyanates. The diisocyanates useful in the present invention 15 include aliphatic or aromatic diisocyanates such as: 4,4'-diphenylmethane diisocyanate (MDI); methylene bis (cyclohexyl) diisocyanate (H 1 2 MDI) including the 4,4' isomer, the 2,4'-siomer and mixtures thereof, the geometrical isomers, trans/trans, cis/trans, cis/cis and mixtures thereof; 20 p-phenylene diidocyanate (p-PDI); trans-cyclohexane-1,4-diisocyanate (CHDI); 1,6-diisocyanatohexane (DICH); 1,6-toluene diisocyanate (2,4-TDI); para-tetramethylxylene diisocyanate (p-TMXDI) and 25 meta-tetramethylxylene diisocyanate (m-TMXDI); 2,4- and 2,6-toluene diisocyanate and their isomer mixtures; isophorone diisocyanate; and 1,5-napthalene diisocyanate. It will be appreciated that this list is not exhaustive and that the invention 30 encompasses any polyisocyanates known to be suitable in the manufacture of polyurethanes.
WO 99/50327 PCT/AU99/00236 -9 The polyurethanes of the present invention may be prepared by any suitable known technique familiar to those skilled in the manufacture of polyurethanes. These methods include manual or mechanical mixing with or without any solvents present, casting, reaction extrusion and reaction injection 5 moulding. A preferred method involves mixing the chain extender/or mixture with a polyisocyanate, preferably a diisocyanate, directly. The silicon chain extender is preferably degassed under vacuum at ambient temperature prior to the polymerisation. If desired, a catalyst such as dibutyltin dilaurate at a level of 0.001 to about 0.5wt% based on the total ingredients and any other desirable 10 additives (eg: antioxidants) may be added to the initial mixture. The appropriate amount of diisocyanate is then added to the silicon chain extender and stirred rapidly to form a clear solution, usually about 30 to 90 seconds, and the polymer cured in an oven at temperatures between 40 and 120 0 C. When mixtures of chain extenders are used the polymerisation may be 15 carried out, first by preparing the chain extender mixture with the desired proportions and then vacuum degassing, followed by adding to the diisocyanate. Alternatively, the preferred method is to add the silicon chain extender first to the diisocyanate and stirring the mixture until the solution becomes clear, and the second chain extender is added quickly afterwards with stirring. 20 Thus, the polyurethane composition of the present invention may be further defined as comprising a reaction product of: (i) a diisocyanate or a polyisocyanate; and (ii) a silicon chain extender or a chain extender mixture defined above. In another aspect, the present invention provides a method of producing a 25 polyurethane including reacting a polyisocyanate with a silicon chain extender or a mixture of chain extenders including a silicon chain extender. The amounts of the chain extender or mixture of chain extenders and diisocyanate or polyisocyanate are chosen, so that the number of moles of the chain extender functional groups (for example hydroxyl groups) are equal to the 30 number of moles of the isocyanate functional groups. It is understood in the art of making polyurethanes that a small excess of about 5 mol % of either the WO 99/50327 PCT/AU99/00236 -10 chain extender or the diisocyanate may be used. When mixtures of two or more chain extenders are used, any combination of chain extender molar ratios could be used provided the total mixture is equimolar with the diisocyanate. The polyurethanes may be processed by conventional methods such as 5 extrusion, injection and compression moulding without the need of processing waxes. If desired, however, conventional polyurethane additives such as catalysts, antioxidants, stabilisers, lubricants, dyes, pigments, inorganic and/or organic fillers, and reinforcing materials such as impact modifiers can be incorporated into the polyurethane during preparation. 10 Polyurethanes of the present invention are easily adaptable to a variety of fabrication techniques including solvent casting, blow moulding, machining to various shapes and other conventional processing techniques such as injection moulding and extrusion. The polyurethane compositions of the present invention are particularly 15 useful in preparing materials having good mechanical properties and clarity, in particular for applications requiring high impact resistance, stiffness, high heat distortion temperature and other structural strength properties similar to polycarbonate, nylon and other engineering thermoplastics. A particularly useful application is in biomaterials, especially for devices and implants 20 requiring one or more of the aforementioned properties. According to another aspect of this invention there is provided a material having improved mechanical properties, clarity and/or degradation resistance comprising a polyurethane composition which includes a silicon chain extender or a mixture of chain extenders as defined above. 25 The present invention provides a series of compositions having good mechanical properties, high heat distortion temperature, high flexural modulus, and preferably free of functional groups such as ester, carbonate, and ether making the materials resistant to degradation under oxidative and hydrolytic environments. Further, the polyurethane composition should also show 30 excellent compatibility and stability in biological environments, particularly when implanted in vivo for extended periods of time. Most preferably, the WO 99/50327 PCT/AU99/00236 -11 compositions of the present invention are substantially free of segments derived from polyols having a molecular weight in excess of 500. Accordingly, the compositions may be used as a biomaterial and the term "biomaterial" is used herein in its broadest sense referring to a material which is 5 used in situations where it comes into contact with the cells and/or bodily fluids of living animals or humans. Thus, the polyurethane compositions in this invention are useful in manufacturing medical devices and implants. In a further aspect, the present invention provides a medical device, article or implant composed wholly or partly of the polyurethane composition 10 described herein. The medical devices, articles or implants may include components of cardiac pace makers, cardiac assist devices, heart valves, extra-corporeal devices, blood pumps, balloon pumps, A-V shunts, biosensors, artificial joints, and orthopaedic implants. Because of the inherent high heat distortion 15 temperatures of these materials it is expected that the polyurethanes are particularly useful for devices requiring dimensional stability at temperatures such as the human body temperature. It is understood that the materials in the present invention will also have applications in the non-medical areas particularly requiring high strength, high 20 flexural modulus, and high heat distortion temperature. Such applications may include their use in the manufacture of structural components for pumps, vehicles, mining screens, laminating compounds, for example in glazing, and etc. According to yet a further aspect, the present invention provides an article 25 composed wholly or partly of the polyurethane composition described herein. The following examples will illustrate the scope of the present invention. These examples are not to be considered as limiting the invention in any way. In the examples, reference will be made to the accompanying drawing in which: 30 Fig 1 is a DSC thermogram of the polyurethane formed according to US Patent No. 4647643.
WO 99/50327 PCT/AU99/00236 -12 Example 1 Three polyurethanes compositions were prepared using 4,4' methylenediphenyl diisocyanate (MDI) and three different chain extender combinations. The three combinations were 1,3-bis(4 5 hydroxybutyl)tetramethyldisiloxane (BHTD) and 1,4-cyclohexanedimethanol (CHDM as a mixture of cis and trans isomers) in BHTD : CHDM molar ratios of 1:0, 1:1 and 1:3. BHTD (Silar Laboratories) was degassed at ambient temperature under vacuum (0.1 torr) for lh prior to polymerisation. CHDM (Aldrich) was melted 10 at 60 0 C and degassed under vacuum (0.1 torr) for lh. All three compositions were prepared by a one-step bulk polymerisation procedure without the use of any catalysts. For the first composition, degassed BHTD (55.68g) was added to molten (50 0 C) MDI (50.00g) in a polypropylene beaker and stirred rapidly until the solution turns clear. After about 3 min of 15 mixing the viscous polymer was poured onto a teflon-coated tray and curd at 100 0 C for 6 hours under nitrogen. The cured polymer was a clear and transparent solid. The second composition (BHTD:CHDM = 1:1) was prepared first by adding BHTD (27.821g) into molten MDI (50.00g) and stirring until the solution cleared (about 60 sec stirring) followed by adding CHDM (14.406g). 20 After stirring the mixture for a further 60sec, the viscous polymer was poured onto a teflon-coated pan and cured under similar conditions. The third composition was prepared by reacting BHTD (13.91g), MDI (50.00g) and CHDM (21.61g) using a procedure similar to that used to prepare the second composition. 25 All three materials were compression moulded at 200 0 C to form Imm thick rectangular plaques which were clear and transparent. Dumbbells punched from this sheet were used to test mechanical properties using an Instron Model 4032 Universal Testing Machine. The thermal transitions of the materials were measured on a Mettler DSC 30 calorimeter in the -150 to 2500 temperature 30 range.
WO 99/50327 PCT/AU99/00236 -13 Table 1 summarises the molecular weight, mechanical properties and the glass transition temperatures. Figure 1 shows the DSC traces of the three polyurethane compositions. As seen from the results, all three materials exhibited high tensile strength, flexural modulus and Shore hardness. It is 5 noteworthy that the increasing CHDM proportion increases these properties as well as the glass transition temperature. Table 1. Properties of polyurethane compositions prepared in Example 1 Property composition- 1 composition-2 composition-3 (BHTD:CHDM= (BHTD:CHDM= (BHTD:CHDM=1:3) 1:0) 1:1) Shore Hardness 75 84 85 (D) Ultimate Tensile 60 68 77 Strength (MPa) Young's 562 713 648 Modulus (MPa) Elongation at 20 31 23 Break (%) Flexural 1795 1940 2130 Modulus (MPa) Molecular 170000 (1.37) 119600 (1.51) 122000 (1.56) Weight (MW distribution) Glass Transition 30 77 98 Temperature- 40 83 105 onset mid point, 58 88 112 end point (oC) WO 99/50327 PCT/AU99/00236 -14 Example 2 Example 2 describes the preparation of three polyurethane compositions based on MDI and three different combinations of BHTD and 1,4-Butanediol (BDO). These included BHTD:BDO molar ratios of 40:60, 50:50 and 60:40. 5 The three compositions were prepared by a one-step bulk polymerisation procedure. Both BDO and BHTD were degassed as described in Example 1. The first composition (BHTD:BDO=40:60) was prepared by weighing degassed BHTD (22.225g) and BDO (10.803g) into a 150mL polypropylene beaker and adding molten (50 0 C) MDI (50.00g) with rapid stirring. The solution 10 cleared after about 1min, and stirring continued until the mixture starts to increase viscosity. The viscous polymer was then poured onto a teflon-coated pan and cured at 100 0 C in an oven for 6 hours under nitrogen. A similar procedure was used to make compositions 2 and 3, except that BHTD (27.821g), BDO (9.003g) and MDI (50.00g) were used for composition 2 while BHTD 15 (33.385g), BDO (7.702g) and MDI (50.00g) were used for composition 3. All three materials were compression moulded to clear and transparent 1mm thick sheets, and dumbbells punched from the sheets were used for testing tensile properties. Table 2 summarises the GPC molecular weights, tensile properties and 20 thermal transitions measured by DSC. These results demonstrate that the chain extender combination BHTD and BDO also produces materials that are clear and transparent with high flexural modulus, tensile strength and high Shore hardness. Results further demonstrate that the high proposition of the conventional chain extender (BDO) yields materials with improved mechanical properties and 25 increased glass transition temperature. 30 WO 99/50327 PCT/AU99/00236 - 15 Table 2. Properties of polyurethane compositions prepared in Example 2 Property compositions- 1 composition-2 composition-3 (BHTD:BDO=40:60) (BHTD:BDO=50:50) (BHTD:BDO=60:40) Shore Hardness 80 82 80 (D) Ultimate Tensile 62 59 55 Strength (MPa) Young's Modulus 576 629 577 (MPa) Elongation at 10 23 12 Break (%) Flexural Modulus 2140 1960 1675 (MPa) Molecular Weight 86160 (1.47) 129990 (1.49) 84700 (1.48) (MW distribution) Glass Transition Temperature - 67 53 55 onset, mid point, 74 61 61 end point (oC) 81 69 67 Example 3 5 This example illustrates the preparation of three polyurethane compositions based the aliphatic diisocyanate hydrogenated MDI (H 1 2 MDI from Aldrich). The first two compositions were based on a mixture of BHTD and CHDM in 1:3 and 1:1 molar ratios, and the third composition was based on BHTD and BDO in 1:1 molar ratio. The diisocyanate was a mixture of three WO 99/50327 PCT/AU99/00236 - 16 isomers, and was used as received. BHTD and CHDM were degassed according to procedures described in example 1 and BDO as in example 2. The first composition (BHTD:CHDM=1:3) was prepared by reacting BHTD (2.654g), CHDM (4.1226g), dibutyltin dilaurate catalyst (0.001g) and 5 H1 2 MDI (10.00 g). The degassed chain extenders and the catalyst were weighed in to a 25mL polypropylene beaker and the diisocyanate heated to 600 was then added quickly in to the beaker and rapidly stirred for 1 min. The polymer was cured in the beaker by placing in an oven at 100C for 12 hours under nitrogen. A similar procedure was used to prepare second and third compositions, 10 except that the second composition (BHTD:CHDM=1:1) was based on; (I) 5.308g of BHTD, 2.748g CHDM, 0.001g dibutyltin dilaurate, and 10.00 g H 12 MDI, while the third composition (BHTD:BDO = 1:1 was based on; (ii) 5.308g of BHTD, 1.717 g BDO, .00 lg dibutyltin dilaurate, and 15 10.00 g H 12 MDI. All three polyurethane compositions were clear, colorless, and transparent. The polyurethanes were compression moulded to 1mm thick plaques at 200 0 C, and dumbbells punched from the sheets were tested for tensile properties on an Instron tensile testing machine. Tensile properties, DSC results, 20 and molecular weights of the polyurethanes are summarised in Table 3. It is noteworthy that even with the aliphatic diisocyanate materials with glass transition temperature of nearly 100 0 C could be produced. 25 30 WO 99/50327 PCT/AU99/00236 -17 Table 3. Properties of polyurethane compositions prepared in Example 3. Property composition- 1 composition-2 composition-3 (BHTD:CHDM= (BHTD:CHDM= (BHTD:BDO = 25:75) 50:50) 50:50) Shore Hardness 75 72 73 (D) Ultimate Tensile 77 67 60 Strength (MPa) Young's Modulus 653 613 522 (MPa) Elongation at 15 28 31 Break (%) Flexural Modulus 1776 1590 1720 (MPa) Molecular Weight 143600 (1.61) 154720 (1.66) 162390 (1.72) (MW distribution) Glass transition Temp. on set, mid 94 65 76 point, 101 71 83 end point (oC) 109 77 89 Example 4 Example 4 describes the preparation of a polyurethane composition based 5 on MDI and a mixture of BPTD:CHDM in a molar ratio (25:75). BPTD ((1,3 bishydroxypropyl) tetramethyldisiloxane) was a commercial reagent purchased from ShinEtsu Chemical Company Ltd (Japan). The composition was prepared by a one-step bulk polymerisation procedure, and both CHDM and BPTD were degassed as described in Example 1.
WO 99/50327 PCT/AU99/00236 - 18 In this example the silicon-based chain extender was added to MDI first followed by the conventional chain extender CHDM. Degassed BPTD (5.005g) was added to molten (50'C) MDI (20g) in a polypropylene beaker and stirred rapidly until the solution turns clear followed by adding CHDM (8.643g). After 5 about 1 min of stirring, the viscous polymer was poured onto a teflon-coated tray and cured at 100 0 C for 6 hours under nitrogen. The cured polymer was a clear and transparent solid. The material was compression moulded at 200oC to form a 1mm thick sheet and dumbbells punched from the sheet were used for testing tensile 10 properties. Ultimate tensile strength 68 MPa, Young modulus 419 MPa, elongation at break 23%, 82 Shore D hardness. Example 5 This example describes the preparation of a polyurethane composition 15 based on MDI and a mixture of 1,4 bis(3-hydroxypropyl) tetramethyldisilylethylene (HTDE) and CHDM the mole ratio of HTDE to CHDM was 25:75. The composition was also prepared by reacting HTDE (5.245g), MDI (20g) and CHDM (8.643g) using a procedure similar to that described in 20 example 4. The cured polyurethane was compression moulded under similar conditions and tested for its tensile properties. The material showed 67 MPa ultimate tensile strength, 464 MPa Young modulus, 22%, elongation at Break, and 78 Shore D hardness. 25 Example 6 This example illustrates the preparation of a polyurethane based on HTDE:CHDM (25:75) and the aliphatic diisocyanate hydrogenated MDI
(H
1 2 MDI, Aldrich). The polyurethane was prepared by reacting HTDE (2.50 lg), CHDM(4.122g), H 12 MDI(10g) and dibutyltin dilaurate (0.001g) and H 1 2 MDI 30 (10g). A mixture of the degassed chain extenders and the catalyst were weighed in to a 25mL polypropylene beaker and the diisocyanate heated to 60 0 C was then WO 99/50327 PCT/AU99/00236 -19 added immediately into the beaker while stirring simultaneously for 1 min. The polymer was cured in the beaker itself at 100 0 C for 12 hours under nitrogen. The polyurethane was compression moulded at 200'C to a 1mm thick plaque and dumbbells punched from the sheet were tested for tensile properties. 5 The material exhibited 70 MPa ultimate tensile strength, 478 MPa Young modulus, 20% elongation at Break and 76 Shore D hardness. Comparative Example 1 This example demonstrates that the compositions disclosed in the prior art 10 (US Patent No. 4647643) do not provide polyurethanes with high modulus, high heat distortion temperatures or the high mechanical strength that is achievable with compositions disclosed in the present invention. A polyurethane composition was prepared according to Example 11 of US Patent No. 4647643. The silicon diol (Q4-3667 fluid) used in this example 15 was obtained from Dow Coming Corporation. The diol Q4-3667 Fluid (7.0g), Terathane T-1000 (53.0g) and BDO (6.667g) were mixed and vacuum stripped (2 torr) at 65 0 C for a minimum of 30 minutes until the cessation of bubbling was noted. Molten MDI (33.430g) was quickly added to the mixture and stirred rapidly with a stainless spatula. After 20 about 1 minute, the contents were poured into a teflon coated metal tray and heated to 125 0 C in a nitrogen circulating oven for 1 hour to complete the polymerisation. After cooling to room temperature, the material was granulated and dried at 65 0 C for 12 hours under vacuum (0.1 torr) before being compression moulded into a flat sheet at temperatures between 190-200 0 C under 25 a nominal load of 8 tons. The polyurethane exhibited 11 MPa ultimate tensile strength, 19 MPa Young's modulus, 520% elongation at break and 35D Shore hardness. The heat distortion temperature of the material was -67 0 C as illustrated in Figure 1. Accordingly, these results clearly demonstrate that US Patent No. 4647643 does 30 not enable the preparation of polyurethane compositions with properties such as WO 99/50327 PCT/AU99/00236 - 20 high heat distortion temperature, high modulus and high tensile strength as in the present invention. References 5 1. D. Dieterich, E. Grigat, W. Hahn, H. Hespe and H.G. Schmelzer, Polyurethane Handbook, G. Oertel Ed Hanser/Gardner Publications, 2nd ed. Chap 2 (1993) 2. Z. Wirpsa, Polyurethanes Chemistry, Technology and Applications Ellis Horwood pp118 (1993) 10 3. F Braun, L. Willner, M Hess and R Kosfeld, J. Organomet. Chem, Vol 332, pp 63-68 (1987) 15 20 25 30

Claims (19)

1. A non-elastomeric polyurethane composition which includes a chain extender of the general formula (1) 5 HO-R 5 -Si- -R 6 -OH R4) (1) 10 wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are the same or different and selected from an optionally substituted straight chain, branched or cyclic, saturated or unsaturated 15 hydrocarbon radical; R 7 is a divalent linking group or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical; and n is 0 or greater.
2. A polyurethane composition as claimed in claim 1, wherein the 20 chain extender has a molecular weight of about 500 or less.
3. A polyurethane composition as claimed in claim 1 or claim 2 wherein the hydrocarbon radical is an alkyl, alkenyl, alkynyl, aryl or heterocyclyl radical or an alkylene, alkenylene and alkynylene radical as appropriate. 25
4. A polyurethane composition as claimed in any one of the preceding claims wherein the divalent linking group is O, S or NR wherein R is hydrogen or an optionally substituted straight chain, branched or cyclic, saturated or unsaturated hydrocarbon radical.
5. A polyurethane composition as claimed in any one of the 30 preceding claims wherein the chain extender of general formula (1) is 1,3-bis(4- WO 99/50327 PCT/AU99/00236 - 22 hydroxybutyl)-tetramethyl disiloxane (compound of formula (1) wherein Ri,-R 2 , R 3 and R 4 are methyl, R 5 and R6 are butyl and R 7 is O), 1,4-bis(3 hydroxypropyl)tetramethyl disilylethylene (compound of formula (1) wherein RI, R 2 , R 3 and R 4 are methyl, R 5 and R 6 are propyl and R 7 is ethylene) or 1,4 5 bis(3-hydroxypropyl)tetramethyl disiloxane.
6. A polyurethane composition as claimed in any one of the preceding claims wherein the chain extender of formula (1) is combined with a chain extender known in the art of polyurethane manufacture.
7. A polyurethane composition as claimed in claim 6 wherein the 10 known chain extender is 1,4-butanediol, 1,6-hexanediol, 1,8-octanediol, 1,9 nonanediol, 1,10-decanediol, 1,12-dodecanediol, 1,4-cyclohexanedimethanol, 1,4-cyclohexanediols and isomers thereof, hydroxyquinone bix(2-hydroxyethyl) ether, 2-ethyl-1,3-hexanediol, 2-butyl-2-ethyl- 1,3-propanediol, 2,2,4-trimethyl 1,3-pentanediol or mixtures thereof. 15
8. A polyurethane composition as claimed in claim 6 or claim 7 wherein the known chain extender is cyclohexanedimethanol or 1,4 butanediol.
9. A polyurethane composition as claimed in any one of the preceding claims which further includes a polyisocyanate.
10. A polyurethane composition as claimed in claim 9 wherein the 20 polyisocyanate is a diisocyanate.
11. A polyurethane composition as claimed in claim 9 or claim 10 wherein the diisocyanate is an aliphatic or aromatic diisocyanate.
12. A polyurethane composition as claimed in claim 10 or claim 11 wherein the diisocyanate is 4,4'-diphenylmethane diisocyanate (MDI), 25 methylene bis (cyclohexyl) diisocyanate (Hl 2 MDI) or isomers thereof, p phenylene diidocyanate (p-PDI), trans-cyclohexane-l1,4-diisocyanate (CHDI), 1,6-diisocyanatohexane (DICH), 1,6-toluene diisocyanate (2,4-TDI), para tetramethylxylene diisocyanate (p-TMXDI); meta-tetramethylxylene diisocyanate (m-TMXDI), 2,4- and 2,6-toluene diisocyanate and their isomer 30 mixtures, isophorone diisocyanate or 1,5-napthalene diisocyanate. WO 99/50327 PCT/AU99/00236 - 23
13. A non-elastomeric polyurethane composition including a reaction product of: (i) a polyisocyanate; and (ii) a silicon chain extender or a chain extender mixture as defined in 5 any one of claims 1 to 12.
14. A method of producing a non-elastomeric polyurethane composition including reacting a polyisocyanate with a silicon chain extender or a mixture of chain extenders including a silicon chain extender as defined in any one of claims 1 to 12. 10
15. A material having improved mechanical properties, clarity and/or degradation resistance including a non-elastomeric polyurethane composition which includes a silicon chain extender or a mixture of chain extenders as defined in any one of claims 1 to 12.
16. A material as claimed in claim 15 which is a biomaterial. 15
17. A medical device, article or implant composed wholly or partly of the non-elastomeric polyurethane composition defined in any one of claims 1 to 13.
18. A medical device, article or implant as claimed in claim 17 which is a component of cardiac pacemakers, cardiac assist devices, heart valves, extra 20 corporeal devices, blood pumps, balloon pumps, A-V shunts, biosensors, artificial joints, and orthopaedic implants.
19. An article composed wholly or partly of the non-elastomeric polyurethane composition as defined in any one of claims 1 to 13. 25 30
AU31292/99A 1998-03-31 1999-03-30 Non-elastomeric polyurethane compositions Expired AU740402B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU31292/99A AU740402B2 (en) 1998-03-31 1999-03-30 Non-elastomeric polyurethane compositions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPP2688 1998-03-31
AUPP2688A AUPP268898A0 (en) 1998-03-31 1998-03-31 High modulus polyurethane compositions
AU31292/99A AU740402B2 (en) 1998-03-31 1999-03-30 Non-elastomeric polyurethane compositions
PCT/AU1999/000236 WO1999050327A1 (en) 1998-03-31 1999-03-30 Non-elastomeric polyurethane compositions

Publications (2)

Publication Number Publication Date
AU3129299A true AU3129299A (en) 1999-10-18
AU740402B2 AU740402B2 (en) 2001-11-01

Family

ID=25621694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31292/99A Expired AU740402B2 (en) 1998-03-31 1999-03-30 Non-elastomeric polyurethane compositions

Country Status (1)

Country Link
AU (1) AU740402B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111334025A (en) * 2020-03-05 2020-06-26 安徽聚力包装制品有限公司 Corrosion-resistant packaging material and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647643A (en) * 1985-11-08 1987-03-03 Becton, Dickinson And Company Soft non-blocking polyurethanes
US5128408A (en) * 1987-11-16 1992-07-07 Toyo Boseki Kabushiki Kaisha Gas-permeable material with excellent compatibility with blood

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111334025A (en) * 2020-03-05 2020-06-26 安徽聚力包装制品有限公司 Corrosion-resistant packaging material and preparation method thereof
CN111334025B (en) * 2020-03-05 2023-03-07 安徽聚力包装制品有限公司 Corrosion-resistant packaging material and preparation method thereof

Also Published As

Publication number Publication date
AU740402B2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
EP1078010B1 (en) Non-elastomeric polyurethane compositions
AU734927B2 (en) Silicon-based polycarbonates
US6858680B2 (en) Shape memory polyurethane or polyurethane-urea polymers
EP1000070B1 (en) Silicon-containing chain extenders
US20070027285A1 (en) Polyurethanes
CA2367678A1 (en) Siloxane-containing polyurethane-urea compositions
US10655012B2 (en) Process for the preparation of polyurethane solutions based on silicon-polycarbonate diols
AU740402B2 (en) Non-elastomeric polyurethane compositions
AU779389B2 (en) Siloxane-containing polyurethane-urea compositions
AU2016274606B2 (en) Synthesis of polycarbonate siloxane diols
AU2004293126B2 (en) Polyurethanes
AU776330B2 (en) Shape memory polyurethane or polyurethane-urea polymers

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ELASTOMEDIC PTY LIMITED

Free format text: THE FORMER OWNER WAS: CARDIAC CRC NOMINEES PTY LTD

TC Change of applicant's name (sec. 104)

Owner name: AORTECH BIOMATERIALS PTY LTD

Free format text: FORMER NAME: ELASTOMEDIC PTY LIMITED

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired